The effect and mechanism of GVS-12 on NASH might be as same as PPARγ agonists.32–34 We assumed that p-hydroxybenzoic acid might be a metabolic product of GVS-12. This evidence concerns the gene PPARG and metabolic dysfunction-associated steatohepatitis.